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CRB2 completes a fully expressed 
Crumbs complex in the Retinal 
Pigment Epithelium
Antonio E. Paniagua, Saúl Herranz-Martín†, David Jimeno‡, Ángela M. Jimeno,  
Saray López-Benito, Juan Carlos Arévalo, Almudena Velasco, José Aijón & Concepción Lillo
The CRB proteins CRB1, CRB2 and CRB3 are members of the cell polarity complex Crumbs in 
mammals that together with Scribble and Par complexes stablish the polarity of a variety of cell 
types. Although many members of the Crumbs complex proteins are expressed in the retinal pigment 
epithelium (RPE), and even though the mRNA of CRB2 has been detected in ARPE-19 cells and 
in the RPE/Choroid, to date no CRB protein has yet been found in this tissue. To investigate this 
possibility, we generated an antibody that specifically recognize the mouse CRB2 protein, and we 
demonstrate the expression of CRB2 in mouse RPE. Confocal analysis shows that CRB2 is restricted 
to the apicolateral membrane of RPE cells, and more precisely, in the tight junctions. Our study 
identified CRB2 as the member of the CRB protein family that is present together with the rest of 
the components of the Crumbs complex in the RPE apico-lateral cell membrane. Considering that the 
functions of CRB proteins are decisive in the establishment and maintenance of cell-cell junctions in 
several epithelial-derived cell types, we believe that these findings are a relevant starting point for 
unraveling the functions that CRB2 might perform in the RPE.
Cell polarity is a known property of cells from unicellular and multicellular organisms, defined as an 
asymmetry in cell shape, protein distribution and cell function1. In multicellular organisms, cell polar-
ization is essential both in the embryonic stage and adulthood for the proper performance of a wide 
range of cellular processes as diverse as synaptic communication between neurons2,3, the formation of 
epithelial barriers to maintain tissue homeostasis4 and the proper distribution of cellular components 
during cell division1. Therefore, cell polarity must be a highly controlled process, which is achieved by 
cell-surface landmarks that adapt core pathways for the correct assembly of the cytoskeleton and protein 
transport. These cell-surface landmarks are thought to be composed of a few evolutionary conserved pro-
teins included in three polarity protein complexes named the Scribble, Par and Crumbs complexes1,3,5–7.
The Crumbs gene was initially identified in Drosophila, where it encodes a transmembrane protein 
that determines apicobasal polarity in embryonic epithelial cells8 and controls the integrity of adherens 
junctions in the adult fly eye9. Drosophila Crumbs contains a large extracellular domain, a transmem-
brane portion and a short intracellular portion8,10–12, which acts as an anchoring point for the assembly 
of the intracellular Crumbs complex10,13,14. The Crumbs complex is typically composed by PALS1, PATJ 
and the Crumbs homologs (CRB) proteins15,16; and plays a crucial role in apical domain specification 
of the plasma membrane3,8,17. To date, CRB proteins have been identified in several organisms, ranging 
from invertebrates to mammals, showing that they are highly evolutionary conserved proteins10,15,18,19. In 
mammals, the CRB family is composed of three members: CRB1, CRB2 and CRB320–22. All three CRB 
proteins share the highly conserved intracellular domain, and whereas CRB1 and CRB2 have a large 
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extracellular component CRB3 lacks this part15,20–22. CRB proteins have been described to be essen-
tial for many cellular processes as the early embryonic development23, formation and maintenance of 
tight junctions24–26 or cell division and ciliogenesis27–29. CRB1 has been extensively investigated because 
CRB1 mutations cause several human retinal dystrophies, such as Leber congenital amaurosis or type 
12 Retinitis Pigmentosa22,30,31. In the mouse retina CRB2 is also essential for the correct expression and 
location of the adherens junctions proteins and removal of mouse Crb2 from retinal progenitor cells 
shows abnormal lamination of the neuroepithelial layer during development and a progressive thinning 
of the photoreceptor layer in adulthood32,33.
The Retinal Pigment Epithelium (RPE) is a highly polarized tissue that is essential for the mainte-
nance of retinal homeostasis34,35. As a polarized epithelium, it expresses some of the Crumbs complex 
members such as MPP1, PATJ, EPB41L5 and PALS136–39 but, unless CRB proteins are necessary for the 
anchorage of the Crumbs complex to the cell membrane7, none of them have been detected in this tissue 
so far. To investigate the expression of one of the members of the CRB protein family in this tissue, we 
designed and generated an antibody that specifically recognize the mouse CRB2 protein inasmuch as, to 
date, all antibodies used in previous studies have failed to fully elucidate the expression of this protein 
in this tissue.
Results
Analysis of the expression pattern of the Crb2 and Crb3 genes. The expression pattern of the 
three Crb genes (Crb1, Crb2 and Crb3) was determined by reverse transcription (RT)-PCR on mRNA 
samples from mouse retina and RPE. The three transcripts are present in the retina as expected but we 
also found that out of the three, CRB2 and CRB3 are also expressed in the RPE (Fig. 1).
Specificity of the CRB2 antibody. To accomplish the present study, we designed a new antibody to 
specifically recognize and discriminate the CRB2 protein. Our goal was to try to improve the detection 
pattern and disparities both by immunofluorescence (IF) and western blot (WB) techniques, shown in 
previous works that used different sets of custom-made antibodies that recognized diverse parts of the 
extracellular domains33,36,40–43.
The specificity of the CRB2 antibody was determined by WB assays. Total protein extracts from 
brain and retina, where the presence of CRB2 has been described were employed as positive controls for 
the expression of CRB236,40. Proteins obtained from skeletal muscle, where CRB2 mRNA has not been 
detected21, were used as a negative control. The CRB2 antibody detected two bands in brain and retina 
extracts, one with an approximate molecular weight of 150 kDa (arrow in Fig.  2A) and another one 
of approximately 260 kDa (arrowhead in Fig.  2A). These two bands were absent in the muscle protein 
extract (Fig. 2A). Furthermore, the same bands were also identified in the RPE protein extract (Fig. 2A). 
To rule out any possible cross-contamination between the RPE and retinal tissues, the synapsin protein 
was chosen as a control marker for nervous tissue and RPE65 was selected as an RPE-specific indicator 
(Fig. 2A). In addition, we used PALS1 to test the expression of a member of the Crumbs complex, which 
we found in brain, retina and the RPE but not in muscle (Fig. 2A). Different methods were employed to 
verify the specificity of the CRB2 antibody. First, we carried out a peptide competition assay, observing 
the almost complete disappearance of the two bands in the control tissues and in the RPE (Fig. 2B). We 
Figure 1. Crb1, Crb2, Crb3 and Actin mRNA amplification in retina and RPE by RT-PCR assays. Crb2 
and Crb3 are transcribed into mRNA in both retina and RPE while Crb1 mRNA is transcribed in retina but 
not in the RPE. Actin amplification levels are similar in both tissues.
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Figure 2. Specificity analyses for the CRB2 antibody and CRB2 expression in the RPE. (A) The CRB2 
antibody detects two bands with approximate molecular weights of 150 kDa (arrow) and 260 kDa (arrowhead) 
in brain, retina and RPE, but not in muscle. A member of the Crumbs complex, PALS1, is also expressed in 
the same tissues. The synapsin protein, only present in brain and retina lysates, and the expression of RPE65, 
only found in RPE, rule out any cross-contamination between retinal and RPE lysates. (B) In the peptide 
competition assay, the two bands detected at 150 and 260 kDa with the CRB2 antibody disappear. GAPDH 
was used as loading control. (C) CRB2 antibody detects a band of approximately 150 kDa in N2A cells. The 
intensity of this band decreases in cells transfected with three different shRNAs of a set of four (shCRB2) 
when compared with shRNA control (shCTR) transfected cells. The numbers indicate the CRB2 increase/
decrease values relative to the shCTR. (D) CRB2-GFP fused protein overexpressed in HEK293 cells (CRB2-
GFP) is detected as a band of 180 kDa by CRB2 and GFP antibodies but not in non-transfected HEK293cells. 
The 150 kDa band is also detected by the CRB2 antibody in both transfected and non-transfected HEK293 
cells. β -actin was used as loading control. (E) CRB3 protein fused to GST is detected wit GST antibody at 
40 kDa but not with CRB2 antibody. RPE tissue was used as a control of CRB2 antibody viability.
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then knocked down endogenous CRB2 in Neuro-2A (N2A) cells by transfecting them with four different 
shRNA sequences against Crb2 mRNA. Three of the four sequences showed a great effectivity knocking 
down Crb2, since the intensity of the 150 kDa band detected in N2A lysates decreased a 49,06% ± 7,19 
for shCRB2#2, a 68,71 % ± 3,90 for shCRB2#3 and a 53,71% ± 14,39 for shCRB2#4 (Fig.  2C). We also 
overexpressed the CRB2 protein fused to GFP in Human embryonic kidney (HEK) 293 cells. The WB 
analysis revealed the exogenous protein at an approximate molecular weight of 180 kDa in the transfected 
cells using both the CRB2 antibody and the GFP antibody (Fig. 2D) and the endogenous CRB2 protein 
at 150 kDa in both transfected and non-transfected HEK293 cells (Fig. 2D). Finally, we wanted to discard 
the possibility that the CRB2 antibody may recognize the CRB3 protein due to aminoacidic similarities. 
To do this, we loaded a commercial CRB3 protein fused to GST and performed immunoblotting with 
the CRB2 antibody. The CRB2 antibody did not recognize the CRB3-GST fusion protein, which was 
effectively detected with the GST antibody (Fig.  2E). We then discarded the possibility that the CRB2 
antibody may cross-react with the CRB3 protein.
Therefore, the CRB2 antibody specifically detects CRB2 at least at 150 kDa that confirms the expres-
sion of CRB2 in mouse RPE cells by WB.
CRB2 is located apically to the proteins of the adherens junctions in the RPE. In order to 
determine the localization of CRB2 in the RPE, we performed detailed confocal imaging analyses in 
RPE flatmounts. The co-immunolabeling with RPE65 (Fig. 3A), a marker specific for RPE cells, and the 
CRB2 antibody (Fig. 3B) showed that CRB2 was mostly located in the plasma membrane of the RPE cells 
(Fig. 3C), although we also found a faint, scattered labeling in the cytoplasm (arrowheads in Fig. 3B,D,F). 
All this labeling disappeared with the peptide competition assay (Fig. 3E).
We then investigated the precise location of CRB2 in the RPE plasma membrane. To do this, we car-
ried out double and triple IF experiments in RPE flatmounts for CRB2 and several apical membrane and 
cell junctions markers present in these cells, such as PALS1 (Fig. 3G), phalloidin (Fig. 3H), which labels 
the F-actin associated with these junctions and p120 catenin (Fig. 4). The triple IF experiments revealed 
that phalloidin, PALS1 and CRB2 colocalized, all of them being detected in the same area of the RPE 
plasma membrane (Fig. 3F–J). Nevertheless, the CRB2 protein showed a more restricted and scattered 
distribution in the plasma membrane than the other proteins, which delineated the entire perimeter of 
the cell junctions’ area.
To obtain a more detailed visualization of the exact location of CRB2 in the apicolateral membrane 
of RPE cells, we analyzed the three-dimensional distribution of this protein, together with some cell 
adhesion proteins, such as p120 catenin (Fig. 4), ZO1 and phalloidin (unpublished data). To accomplish 
this, we obtained Z-stack images by confocal microscopy, and found p120 catenin located in the api-
colateral membrane (Fig. 4B,E,H,K) while CRB2 was located in a narrower range apically to p120 cat-
enin (Fig. 4A,D,G,J). These proteins did colocalize, but in a very specific area (Fig. 4G–I). Likewise, the 
orthogonal view of the Z-stack (Fig. 4M) and the three-dimensional reconstruction performed with these 
images to pinpoint the location of the two proteins demonstrated that CRB2 was positioned apically to 
p120 catenin in the apicolateral membrane of RPE cells (Fig. 4N,O and Video file).
Discussion
As a polarized epithelium, the RPE expresses some of the Crumbs complex proteins20,36–40, although, 
to date, none of the three CRB protein family members had been detected. Given the relevance that 
CRB proteins have shown in other cells or tissues22,23,44 and the importance of polarity for the RPE 
functions45,46, the aim of this study was to unravel whether CRB2 is expressed in the mouse RPE and to 
determine its precise localization in this tissue.
In the present work, we have demonstrated the presence of the mRNA of Crb2 in the mouse RPE 
and confirmed the absence of Crb1 mRNA, in agreement with a previous work where Crb2 mRNA was 
detected in RPE/Choroid and ARPE1921. Additionally, the presence of Crb3 mRNA in the RPE observed 
in the present study had not been described in previous studies. However, subsequent studies have not 
been able to detect the expression of any of these proteins in the RPE. One of the reasons that could 
explain this circumstance is that the specific conditions used in the detection protocols when using these 
antibodies were not the most suitable for the antibodies and techniques that were used. Many of these 
antibodies are directed against the extracellular domain of CRB2, none of them have been commercial-
ized so far or have been designed to recognize the human CRB2 protein33,36,40–43. Furthermore, there is 
substantial controversy regarding the precise molecular weight of this protein, since these publications 
either do not show any WB analysis, or in the case they do, these studies do not agree in conferring 
a certain molecular weight to CRB2 or show many bands of diverse molecular weight in different tis-
sues40–42,47. To try to solve these inconsistencies and to elucidate the presence of CRB2 in the mouse 
RPE, we designed and characterized a specific antibody against the cytoplasmic domain of mouse CRB2.
Our WB data support the expression of the CRB2 protein in the RPE, as well as in the brain and 
retina, where it had been already detected33,36,40. Even though the predicted molecular weight for CRB2 is 
134 kDa (Universal Protein Resource), we have detected two bands in these tissues, one of them slightly 
under 150 kDa and the other one above 260 kDa. These results are partly consistent with those reported 
in a previous study in which CRB2 was detected as three bands of 80, 150 and 200–220 kDa in mouse 
embryonic stem cells42 and with an additional band of 220 kDa in forebrain lysates of mouse embryos 
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Figure 3. CRB2 detection by IF on RPE flatmounts. RPE65 (A) is expressed in RPE cells together with 
CRB2 (B). (C) Merged images of RPE65 and CRB2 labeling and nuclei in blue. (D) CRB2 is located in the 
cell membrane of RPE cells. (E) The CRB2 labeling disappears after the peptide competition assay. Nuclei are 
stained in blue in (D,E). Triple IF showing CRB2 (F), PALS1 (G) and phalloidin (H) in the cell membrane. 
CRB2 and PALS1 colocalize in the cell membrane (I) together with phalloidin (J). Arrowheads in (B,D,F): 
scattered punctate labeling for CRB2 in the cytoplasm. Scale bars: 20 μ m.
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Figure 4. Accurate location of CRB2 in the cell membrane of RPE cells. (A–L) Confocal microscopy 
Z-stack images of a triple immunolabeling for CRB2 (red), p120 catenin (green) and nuclei (blue) in RPE 
flatmounts obtained from the basal to apical cell sides with a step size of 300 nm. In the lateral membrane, 
p120 catenin is expressed more basally (B,E,H) and CRB2 is located apically (G,J). None of these proteins is 
located at the basal side of the cell membrane (arrowheads in A–C). Towards the apical side, p120 catenin 
appears (arrowhead in E,F), but not CRB2 (arrowhead in D). Both proteins colocalize in the cell membrane 
across a short range (arrowheads in G–I). CRB2, but not p120 catenin, is localized at the apical-most side 
of the cell membrane analyzed (arrowheads in J–L). In (C,F,I,L) an RPE cell scheme represents the relative 
position where each image was acquired. The black line in C represents the portion of the RPE where 
none of the proteins studied are located. The green line in F is where only p120 catenin is located. The 
yellow line in (I) is where both proteins (p120 catenin, green and CRB2, red) colocalize. The red line in (L) 
represents the area of the RPE cell where CRB2, but not p120 catenin, is present. (M) maximal projection 
and orthogonal view of the Z-stacks shows the location of the two proteins (arrowheads) in the apical side 
of the cells. (N) a three-dimensional reconstruction of the Z-stack shows that CRB2 is located apically to 
p120 catenin. (O) intracellular staining was removed to facilitate the examination of the membrane labeling. 
Arrows in the upper right margin in (N,O) indicate the orientation from basal (base of the arrow) to apical 
side of the cells (arrowhead). A movie of this 3D reconstruction is available on “Video file”. Scale bars: 20 μ m.
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of 13.5 days40. The overexpression of CRB2 fused to GFP in HEK293 showed the exogenous protein at 
180 kDa that was detected with both, CRB2 and GFP antibodies. The endogenous 150 kDa band was 
clearly identified in the two cell lines used for the different experiments in the present study, which was 
effectively knocked down in the N2A cells, confirming the specificity of the CRB2 antibody. Despite the 
fact that this antibody was generated to detect the mouse protein, it seems that it also distinguish the 
human CRB2 in HEK293 cells, probably because of the high similarity of their cytoplasmic domains. 
However, we could not detect the heaviest 260 kDa band in any of the cell lines employed in our study, 
becoming more difficult to confirm the specificity of the 260 kDa band detected in tissue lysates. The 
complexity of the cell organization required in a tissue differs from that of a cell culture, and that could 
explain the presence of different isoforms, post-translational modifications or even protein aggregates in 
tissue protein extracts. Further studies are needed to confirm this observation.
Regarding the detection of the CRB2 protein in tissue, although previous studies have shown the 
expression and location of CRB2 in retina sections that include the RPE cells tissue layer32,33,36,48, none 
of them has reported the expression of this protein in the RPE. This could be due to the conditions of 
the procedures, as the tissue processing (e.g., retina cryosections, RPE flatmounts), the fixation time, the 
fixative concentration or the antibodies used, since these conditions are critical for the preservation and 
detection of many antigens. In fact, a clear example of the convenience of using the appropriate tissue 
processing is that we were not able to detect CRB2 in RPE cells in tissue cryosections (data not shown) 
but only in RPE flatmounts. Interestingly, this observation is not unusual since one of the Crumbs com-
plex proteins, PALS1, was not detected in the RPE in retina sections either38,49–51 but only using the RPE 
flatmounts procedure38. The detailed confocal microscopy analysis of RPE flatmounts for CRB2 and pro-
teins such as p120 catenin and PALS1 and 3D reconstruction analyses allowed us to discern that CRB2 
is located in a narrow area situated apically to the zone where the adherens junction are located, what is 
in agreement with the location of Crumbs complex proteins in other cells25,52–54.
The Crumbs complex protein PALS1 has been described to be essential for the RPE and retina struc-
ture maintenance38,55. Interestingly, we found that the staining of CRB2 and PALS1 did not completely 
overlap, since CRB2 showed a patchy distribution in the RPE cell membrane, differing from the more 
continuous PALS1 staining throughout it. These data suggest that in the RPE cell membrane PALS1 may 
not always be bound to CRB2. We have demonstrated that Crb3 mRNA is expressed in these cells so it is 
possible that CRB3 protein could be also expressed in the RPE cells since it has been detected in several 
epithelial cell lines20,24,44,54,56. The co-expresion of both members of the CRB family in the same cell has 
already been reported15,49 and although both proteins are very similar, CRB3 (28 kDa), which contains 
a shorter extracellular portion20 is involved in many diverse processes, as cell division or ciliogenesis in 
other epithelial cells27,29. This way, the expression of another member of the CRB protein family is still 
unexplored and needs to be elucidated to better understand the mechanisms in which these two CRB 
proteins might be implicated.
Our IF experiments in RPE flatmounts also show a scattered and punctate cytoplasmic labeling for 
CRB2 on these cells. Previous studies in Drosophila reported that an active traffic between the plasma 
membrane and cytoplasmic vesicles is necessary for the control of Crumbs protein function57,58. In mam-
malian MDCKII (Madin-Darby Canine Kidney II) cells a noteworthy trafficking of CRB3 protein has 
recently been demonstrated, where an important amount of this protein has been detected in the cyto-
plasm as well as in the apical cell membrane56. Our results suggest that the punctate labeling obtained 
for CRB2 in the cytoplasm of RPE cells could correspond to the different spots of localization of the 
protein while travelling from or towards the membrane, although further studies are needed to prove 
this observation.
We have tried to confirm the specificity of the CRB2 immunolabeling in IF experiments by knocking 
down this protein from N2A cells. Unfortunately, maybe due to the incomplete knock down by using 
this procedure together with the fact that IF is mainly qualitative and not quantitative enough, we have 
not been able to get definitive conclusions out of the IF experiments after knocking down CRB2 from 
N2A cells. However, both the precise location of CRB2 in RPE cells that is in agreement with the location 
of the Crumbs complex proteins in epithelial cells20,25,52–54 and all the experiments performed by WB 
showing the distinct expression of CRB2, strongly support the specificity of the IF labeling for CRB2 in 
RPE cells.
In conclusion, our findings are relevant because this is the first time that any of the CRB proteins have 
been found in RPE. To date, RPE cells were an exception, since it is a cell type where some members of 
the Crumbs complex proteins but none of the CRB proteins had been detected. This way we have demon-
strated that, at least in the RPE, a fully Crumbs complex is expressed, probably being CRB2 the protein 
that anchors the polarity complex to the cell membrane. In light of this, considering the importance of 
proper RPE cell adhesion organization and polarization for the maintenance of retinal homeostasis, and 
bearing in mind the retinal disorders caused by the improper functioning of Crumbs complex in these 
tissues, we believe that these findings are a relevant starting point for gaining further insight into a pos-
sible role of these proteins in the correct performance of the functions of the RPE.
www.nature.com/scientificreports/
8Scientific RepoRts | 5:14504 | DOi: 10.1038/srep14504
Materials and Methods
All procedures used in this work were in accordance with the guidelines of the European Communities 
Council Directive 2010/63/UE and the RD 53/2013 Spanish legislation for the use and care of animals. 
All the details of the study were approved by the Bioethics Committee of the University of Salamanca.
Animals. For this study, we used 90-day-old adult wild-type C57BL/6J mice that were euthanized with 
carbon dioxide prior to tissue extraction.
RT-PCR analyses. To verify Crb1, Crb2 and Crb3 and Actin mRNA expression, four pairs of prim-
ers were designed from the corresponding gene sequences and used for RT-PCR analyses using mouse 
retina and RPE cDNA. Crb1 (exon 6): Forward 5′ -ACAAGTGGCTCCCATACAGG-3′ and Reverse 
5′ -ACGAAATGCCATTCTCCATC-3′ , Crb2 (exons 2–4): Forward 5′ -GCAGATCACTACGAGTGCC-3′ 
and Reverse 5′ -CCGGAAACCGTTGACCAG-3′ , Crb3 (exons 2–4): Forward 5′ -TAACAGCACCGGA 
CCC-3′ and Reverse 5′ -ACTCCCAGAATGGAAAAGAC-3′ , Actin: Forward 5′ -AGCCATGTACGTAG 
CCATCC-3′ and Reverse 5′ -ACCCTCATAGATGGGCACAG3′ . After the animals had been sacrificed, 
the eyes were dissected out, the cornea and lens were removed, the retina was extracted and the RPE 
was separated from the choroid using fine forceps. The retina and the RPE were lysed in TRIzol® LS 
Reagent (Life TechnologiesTM) and total RNA was isolated following the manufacturer’s instructions. 
Total RNA was treated with TURBO DNA-freeTM kit (Life TechnologiesTM) to digest trace amounts of 
genomic DNA. Randomly primed cDNA synthesis was performed using the RETROscript® kit (Life 
TechnologiesTM) in accordance with the manufacturer’s instructions. Specific sequence amplifications of 
the Crb1, Crb2, Crb3 and Actin genes were performed with PCR using 300 μ g of cDNA and 0.2 μ M to 
0.5 μ M of specific primers in 20 μ l of PCR solution under the following conditions: an initial denatura-
tion period of 3 minutes at 94 °C followed by an amplification period of 35 cycles for 45 seconds at 94 °C, 
30 seconds for annealing at 49 °C in the case of Crb1 pair of primers and 56 °C for Crb2, Crb3 and Actin 
pairs of primers and 30 seconds at 72 °C, and a final extension timing of 10 minutes at 72 °C.
To analyze the RT-PCR reaction, 20 μ l of each product was loaded onto a 2% agarose gel in the pres-
ence of ethidium bromide and visualized under a UV light transiluminator.
Negative controls such as minus-RT and a minus-template PCR ruled out any DNA contamination 
of the RNA samples or the PCR reagents.
Cell cultures and transfection. N2A cells were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 1% MEM Non-Essential Amino 
Acids, 1% penicillin/streptomycin and 1% sodium pyruvate. pLVTHM plasmid59 encoding either the shRNA 
sequence 5′ -cgcgtGCGCGCTTTGTAGGATTCGttcaagagaCGAATCCTACAAAGCGCGCtttttggaaat -3′ 
from Euglena gracilis chloroplast that does not hybridize with any region of the mouse transcriptome as 
a negative control or the shRNAs sequences against mouse Crb2:
#1.5′ -cgcgtGTGCCAGGCTACAGAAAGTttcaagagaACTTTCTGTAGCCTGGCACtttttggaaat-3′ .
#2.5′ -cgcgtTGACTTCTACTGCACCTGCttcaagagaGCAGGTGCAGTAGAAGTCAtttttggaaat-3′ .
#3.5′ -cgcgtCGAAGTGGATGAGGACGAAttcaagagaTTCGTCCTCATCCACTTCGtttttggaaat-3′ .
#4.5′ -cgcgtCCACCAGAGGAGAGACTTAttcaagagaTAAGTCTCTCCTCTGGTGGtttttggaaat-3′ , were 
transfected into N2A cells with Lipofectamine® LTX and Plus™ Reagent (Life TechnologiesTM) follow-
ing the manufacturer’s instructions. Cell lysates were collected 36 hours after transfection as described 
below. Three different experiments were performed and quantified. Data are represented as means ± SEM 
(Standard Error of the mean).
HEK293 cells were cultured in DMEM supplemented with 10% heat-inactivated fetal bovine 
serum, 1% MEM Non-Essential Amino Acids, 1% penicillin/streptomycin and 1% sodium pyru-
vate. pCMV6-AC-GFP plasmid encoding the CRB2 protein with a C-terminal tGFP tag (OriGene 
Technologies) was transfected into HEK293 cells following the calcium phosphate method, as described 
in60. Total proteins were collected 24 h post-transfection as described below.
Antibody production. The NCBI database (http://www.ncbi.nlm.nih.gov) was used to choose a 
unique antigenic amino acid sequence of the mouse CRB2 protein to design an antibody. The sequence 
of choice of the CRB2 protein, containing amino acids 1243 to 1256 with a cysteine at the N-terminal 
end, was sent to GenScript Corporation™ for the generation and purification of the corresponding pol-
yclonal antibody.
Protein extraction and Western blot analyses. The RPE, retina, a portion of brain, a fragment of 
skeletal muscle, N2A and HEK293 cells in culture were lysed in RIPA buffer (150 mM sodium chloride 
1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris, pH 8.0) with 
protease inhibitor cocktail (1:1000, Sigma-Aldrich™ ). Each piece of tissue was homogenized in separate 
tissue grinders and maintained under constant shaking for 2 h at 4 °C. The resulting solutions were cen-
trifuged at 15,000 g for 20 min at 4 °C. The supernatants were collected and the protein concentrations 
were assayed with Bradford’s assay, and equal amount of proteins was loaded in each lane.
To discard the possibility that the CRB2 antibody may recognize the CRB3 protein due to aminoac-
idic similarities, we used 1 · 10−3 nmol of CRB3 fused to GST (Abnova) mixed with the same amount of 
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purified BSA (Promega). The later was used to stablish the background threshold of nonspecific binding 
of the antibody.
Proteins were dissolved in sample buffer (2% SDS, 10% glycerol, 700 mM β -mercaptoethanol, 62.5 mM 
Tris-HCl, pH 6.8, 0.05% bromophenol blue), and loaded on a SDS-polyacrylamide gel under reducing 
conditions. After electrophoresis, proteins were transferred to PVDF membranes, blocked for 1 h at RT 
in a solution with 2% BSA in Tris-buffered saline-Tween (0.1%) (TBST), and immunolabeled overnight 
at 4 °C with the following primary antibodies: rabbit CRB2 antibody (custom-made, 5 μ g/ml), mouse 
β -actin antibody (Sigma-Aldrich™ , 1:5000), mouse GAPDH antibody (Sigma-Aldrich™ , 1:10000), rab-
bit GFP antibody (Clontech, 1:1000), rabbit GST antibody (custom-made61, 0.5 μ g/ml), mouse PALS1 
antibody (Abnova, 1:1000), mouse RPE65 antibody (Abcam™ , 1:5000) and mouse Synapsin antibody 
(Synaptic Systems, 1:1000) in a solution with 2% BSA in TBST. After several washes with TBST, the 
membranes were incubated with 1:5000 anti-rabbit IgG or 1:30000 anti-mouse IgG conjugated with alka-
line phosphatase (Jackson ImmunoResearch™ ) in 2% BSA, 2% milk in TBST for 60 min at RT, washed 
with TBST, and developed with NBT (Nitro-blue-tetrazolium, Roche Applied Science™ ) and BCIP 
(5-bromo-4-chloro-3-indolyl-phosphate, Roche Applied Science™ ) or incubated with 1:10000 anti-rabbit 
IgG, 1:10000 anti-mouse IgG (Jackson ImmunoResearch™ ) or 1:10000 protein-A (Life TechnologiesTM) 
conjugated with horseradish peroxidase in 2% BSA and 2% milk in TBST for 60 min at RT, washed with 
TBST, and developed with Pierce™ ECL Plus Western Blotting Substrate (Thermo Scientific).
We also carried out a peptide competition assay as a negative control. To accomplish this, the CRB2 
antibody was incubated with 0.2 mg/ml of the corresponding original antigen fusion protein for 1 h at 
RT, and this mixture was used instead of the primary antibody dilution.
Immunofluorescence. To obtain RPE flatmounts, after the animals had been sacrificed their eyes 
were extracted and the lens and retinas were removed. Then, the RPE and choroid were fixed by immer-
sion for 10 min in PFA 4%. Following this, the fixed tissue was washed in 0.2% PBS-Tx and blocked for 
1 h in a solution with 1% BSA and 5% normal serum in 0.2%PBS-Tx and then incubated ON at 4 °C in a 
solution containing 1% BSA and 2% normal serum in 0.2% PBS-Tx and the following primary antibod-
ies: rabbit CRB2 antibody (custom-made, 5 μ g/ml), mouse PALS1 antibody (Abnova, 1:250), Phalloidin 
(Sigma-Aldrich™ , 1:500), mouse p120 catenin antibody (BD Transduction Laboratories, 1:100), mouse 
RPE65 antibody (Abcam, 1:1000). Then, flatmounts were washed with 0.2% PBS-Tx and incubated for 
1 h at RT with 1:500 Alexa fluor 488 and/or 1:500 Alexa fluor 555 fluorescent secondary antibodies (Life 
TechnologiesTM) and the nuclear-staining TOPRO-3 (Life TechnologiesTM, 1:1000) in 1% BSA and 5% 
normal serum in 0.2%PBS-Tx. Flatmounts were placed with the choroid facing the slide and the RPE 
facing the cover slip and mounted using Prolong™ Gold antifading reagent (Life TechnologiesTM).
Negative controls for the flatmounts immunolabeling were performed by removing the primary or 
secondary antibodies. We also carried out a peptide competition assay, as previously described in the 
WB analyses, to discriminate any possible background labeling.
Imaging. All images were obtained with a laser scanning spectral confocal microscope (Leica TCS 
SP2) with the pinhole set at 1.2 Airy Units and 40x and 63x immersion oil objectives. 488 nm, 543 nm and 
633 nm laser lines were used to excite the Alexa 488, Alexa 555 and TOPRO3 fluorochromes respectively, 
and the three different channels were captured in sequential mode. Minor adjustments of contrast and 
brightness were performed with Adobe Photoshop CS5 software and Leica Confocal Software. For the 3D 
reconstructions, thirty-five optical sections were obtained with a voxel depth of 284.9 nm, covering a total 
depth of 8.8 μ m. The image stack obtained was then imported into ImageJ using the LOCI Bio-formats 
plug-in, and the 3D reconstruction was accomplished using the 3D viewer plug-in for Image J.
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